-
Liminal BioSciences Inc. (LMNL)
-
Knight Therapeutics Inc. (GUD $6.40)
-
Merus Labs International Inc. (MSL $1.65)
Q: I read your summary back in December on MSL. It was not flattering. As you expected the stock continues to languish. Are there other Companies in this space you would prefer and would you sell MSL (small holding) to buy it?